Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 31, 2008

View Archived Issues

Finally Something Positive! Two UK Investor Funds Close

LONDON - There may be signs of life yet in biotech investing. (BioWorld International) Read More

EMEA 2009 Plan Includes More Help for the Industry

Human Blood Cancers Highlight New Approach to Therapies

UK Company Points Way to More Predictive Rat Models

NicOx/Topigen Discontinue COPD Work on TPI 1020

Paladin Labs Acquires ViRexx with Bankruptcy Financing

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...